Abstract
Restless legs syndrome (RLS) is a poorly understood, often distressing condition that is particularly prevalent among patients with chronic renal failure. A wide variety of medications have been used to treat RLS with variable results. In order to evaluate the efficacy of carbidopa/levodopa therapy, eight consecutive uremic patients with RLS on maintenance hemodialysis were treated with doses ranging from 25/100 to 25/250 twice daily. Six of eight patients obtained satisfactory relief which has continued for 3 months follow-up. Carbidopa/levodopa appears to be an effective option in management of RLS in patients with chronic renal failure.
Original language | English (US) |
---|---|
Pages (from-to) | 233-235 |
Number of pages | 3 |
Journal | International Journal of Neuroscience |
Volume | 35 |
Issue number | 3-4 |
DOIs | |
State | Published - 1987 |
Keywords
- Chronic renal failure
- L-dopa
- Restless legs syndrome
ASJC Scopus subject areas
- Neuroscience(all)